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Background & Aim: Men have a higher prevalence of liver disease. Liver myeloid cells
can regulate tissue inﬂammation, which drives progression of liver disease. We
hypothesized that sex alters the responsiveness of liver myeloid cells, predisposing
men to severe liver inﬂammation.
Methods: Luminex was done on plasma from Hepatitis B Virus infected patients
undergoing nucleoside analogue cessation in 45 male and female patients. We
collected immune cells from the sinusoids of uninfected livers of 53 male and female
donors. Multiparametric ﬂow cytometry was used to phenotype and characterize immune
composition. Isolated monocytes were stimulated with TLR ligands to measure the
inﬂammatory potential and the expression of regulators of TLR signaling.
Results: We conﬁrmed that men experienced more frequent and severe liver damage
upon Hepatitis B Virus reactivation, which was associated with inﬂammatory markers of
myeloid activation. No differences were observed in the frequency or phenotype of
sinusoidal myeloid cells between male and female livers. However, monocytes from
male livers produced more inﬂammatory cytokines and chemokines in response to TLR
stimulation than female monocytes. We investigated negative regulators of TLR signaling
and found that TOLLIP was elevated in female liver-derived monocytes
Conclusions: Our data show that enhanced responsiveness of myeloid cells from the
male liver predisposes men to inﬂammation, which was associated with altered
expression of negative regulators of TLR signaling.
Keywords: sex, liver, monocytes, Hepatitis B virus, TLR signaling
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and TGF-b in response to LPS to maintain the suppressive liver
environment (9). However, exposure to pathogen-associated
molecular patterns (PAMPs) breaks the tolerogenic environment,
triggering an inﬂammatory cascade that recruits inﬂammatory
immune cells to the liver, causing non-speciﬁc hepatocyte
killing (10). Resident within the liver and sinusoids, and recruited
early in the inﬂammatory process, is a signiﬁcant monocyte
population with the plasticity to develop into inﬂammatory
macrophages (11, 12). Given the central role of myeloid cells
in the inﬂammatory process, we hypothesized the myeloid
population within the liver may be an important source of the
sexual dimorphism observed in the progression of chronic
liver inﬂammation.
To investigate this hypothesis, we ﬁrst validated the male-bias
for hepatitis in a clinical cohort of chronic hepatitis B (CHB)
patients that developed liver inﬂammation due to Hepatitis B
virus (HBV) reactivation. Subsequently, we analyzed the
composition and functional proﬁle of immune cells isolated
from uninfected donor livers prior to transplant. Our data
indicate that biological sex did not signiﬁcantly alter the
composition or phenotype of myeloid cells derived from the
human liver. However, exposure to Toll-like receptor (TLR)
ligands unmasked a signiﬁcant sex-bias in the inﬂammatory
potential of intrahepatic monocytes. Finally, we suggest that
males are at a higher risk for the development of liver disease
due to lower expression of negative regulators of NF-ĸB
signaling. Our data provides evidence in the human liver to
explain male-biased progression of inﬂammatory liver disease.

LAY SUMMARY
800 million people are at risk of developing cirrhosis as a result of
chronic liver disease and this can put people at higher risk for
liver cancer. The progression of chronic liver disease is caused by
altered regulation of the immune response in the liver by viral
infection, alcoholism or obesity. These external factors cause
over-activation of immune cells in the liver, which kills liver cells,
hepatocytes, which are then replaced by scar tissue.
Epidemiological data clearly indicates that men are more likely
to develop cirrhosis and liver cancer. We hypothesized that
immune cells in the liver of men display enhanced activation
to environmental triggers like viral infection, compared to
women. We show here that speciﬁc immune cells in the liver,
monocytes, look similar between men and women but show
potential for enhanced inﬂammation upon activation. This
enhanced inﬂammation could explain increased risk for men
to develop cirrhosis and liver cancer.

INTRODUCTION
The liver is central to the overall health of the individual. The
physiological function of the hepatocyte containing parenchyma
contributes to nutrient transport, energy, fat storage, digestion,
clotting factor production, and detoxiﬁcation (1). However, the
liver is also considered an immunological organ (2). The entire
blood volume ﬂows through the liver every 5 min, with 80% of that
blood derived from the portal venous system (1). Portal blood is
laden with bacterial and food antigens that are removed by immune
cells lining the unique capillary bed of the liver. This system, when
working properly, removes potentially toxic substances with
minimal inﬂammation or damage to the normal physiological
function. However, when dysregulated, the intrahepatic immune
system causes chronic inﬂammatory disease that leads to ﬁbrosis
and cirrhosis, potentially ending in liver cancer (3).
Recent estimates put more than 800 million people at risk for
the development of cirrhosis as a result of chronic liver
inﬂammation (4). Epidemiological data highlights a clear
disparity, based on sex, that underlies progression of liver
disease. Men are more likely to develop cirrhosis than women
(5), translating to the fact that men are three times more likely to
develop liver cancer than women (6). Overall, men are more
likely to die from chronic liver disease than women (7). Given the
different outcomes of liver disease in men, compared to women,
we hypothesized that the intrahepatic immune system would
display differences in either composition or function between
men and women.
Under normal conditions, the liver displays a tolerogenic
environment that suppresses immune activation in the tissue (8).
This environmental regulation is primarily controlled by liver
and sinusoid resident myeloid cells, including macrophages and
monocytes. Liver macrophages, or Kupffer cells, are a
heterogeneous population of macrophages that produce IL-10
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MATERIALS AND METHODS
Ethics Statement
Peripheral blood and liver perfusion samples were collected from
Saint Louis University Hospital and Barnes Jewish Hospital, in
collaboration with Mid-America Transplant Services in Saint
Louis, Missouri. Perfusion samples were also collected at the
Toronto General Hospital, Toronto, Canada. Informed, written
consent was obtained from next of kin. The study was approved
by the Saint Louis University institutional review board and the
University Health Network research ethics board.

Plasma Samples From Chronic
Hepatitis B Patients
Plasma was collected from 45 patients who underwent a
protocol-deﬁned stop to their antiviral therapy for chronic
HBV infection. The clinical characteristics of the patients and
outcome of the study was previously published (13). Patient
plasma was analyzed using a custom Luminex Bead Assay (R&D
Systems) to measure CD14, soluble CD163 (sCD163), IL-1a, IL1b, IL-6, TNF-a, FAS-L, TRAIL, and CXCL10 in serum of
patients at baseline, 12 w and 18 w after stopping therapy.
Each patient’s baseline measurements were subtracted from the
12w and 18w samples to normalize change from baseline.
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streptomycin, non-essential amino acids, and 1mM sodium
pyruvate. Cells were treated with 1 mM beta-estradiol (EST) or
5a-Dihydrotestosterone (DHT) for 18h and then stimulated with
R848 (1 µg/ml) or TL8-506 (TLR8 agonist, 0.1 µg/ml) for 6h in
the presence of 10 µg/ml Brefeldin A. Following the stimulation,
PBMC were stained with viability dye and stained for CD14.
Cells were permeabilized with cytoﬁx/cytoperm (BD Biosciences)
and stained for IL-6 or CCL4 for 30 min at 4°C, washed and ﬁxed in
1% paraformaldehyde. Samples were acquired and analyzed using
ﬂow cytometry as described above.
To measure TLR expression, IHMC samples from 5 male and
5 female liver donors were stained for viability, CD14, and TLR5,
followed by intracellular TLR8 staining in the method described
above. Samples were acquired and analyzed using ﬂow cytometry
as described above.

Blood Collection and Processing
Blood was collected by standard venipuncture. PBMC were
collected by density gradient centrifugation and cryopreserved
in liquid nitrogen in 90% knockout serum replacement (KO; Life
Tech) + 10% DMSO (Sigma).

Collection and Characterization of
Sinusoidal Resident Intrahepatic
Mononuclear Cells
Non-adherent sinusoidal resident intrahepatic mononuclear
cells (IHMC) were isolated from the livers of cadaveric donors.
Liver donor characteristics can be found in Supplementary
Table 1 and the distribution of cause of death in
Supplementary Table 2. Peripheral blood and liver perfusion
samples were collected at the Mid-America Transplant Services
for organs assigned for transplant at the Saint Louis University
Hospital or Barnes-Jewish Hospital Abdominal Transplant
Programs. Samples were also collected at the Toronto General
Hospital. After blood collection, peripheral blood was removed
from the liver by aortic ﬂush and IHMC were collected by liverspeciﬁc, back table, portal vein perfusion with 1L of University of
Wisconsin solution. Mononuclear cells were concentrated using
centrifugation at 300xg for 10 min before being layered over
ﬁcoll (GE healthcare) to remove residual red blood cell
contamination. Following density gradient separation, cells
were cryopreserved as above.

Quantitative PCR of the TLR Pathway
IHMC monocytes from 6 patients were isolated as described
above. Following isolation, RNA was isolated using a RNeasy
micro kit (Qiagen) and quantiﬁed using a NanoDrop 2000. 350
ng of RNA was reverse transcribed using a High-Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Gene
expression was measured with pre-designed TaqMan Gene
Expression Assay (FAM) kits (Thermo Fisher). TaqMan qPCR
was performed using TaqMan Fast Advanced Master Mix
(Applied Biosystems) on a QuantStudio 6 thermocycler
(Applied Biosystems) to investigate the expression of TLRs and
regulators of TLR and expression was normalized to the
expression of beta-2-microglobulin

Flow Cytometry
IHMC (1x106 cells) were stained with ﬁxable viability dyes
(ThermoFisher Scientiﬁc) and ﬂuorochrome conjugated
antibodies listed in Supplementary Table 3. Samples were
acquired on BD ﬂow cytometry instruments and analyzed with
FlowJo V10 software (TreeStar Inc). Live singlet monocytes
(CD14+CD3-CD7-CD19-CD20-CD56) were down-sampled to
5000 per sample and concatenated before tSNE dimensionality
reduction analysis in FlowJo using the following markers for
monocytes: CD32, CD64, HLA-DR, CD11b, CD11c, CD35,
CD163, CD68, and CD88

TOLLIP Western Blot
CD14 monocytes from 10 PBMC and 12 IHMC donors were
isolated as described above (PBMC: n = 5 male, 5 female; IHMC:
n = 4 male, 8 female). Cells were lysed with RIPA Buffer with
Protease Inhibitors (Thermo Scientiﬁc) according to
manufacturer description. Cell lysate was run on a 12%
reducing acrylamide gel and transferred to a PVDF membrane.
The membrane was blocked for 90 minutes with MilliQ water
with 5% skim milk. TOLLIP (Biolegend) and actin (BD
Biosciences) staining was done 1:1000 and 1:10,000,
respectively, in TBST with 2% BSA for 1 hour. Secondary
staining with HRP conjugated anti-murine IgG at 1:2000
(Biolegend) in TBST with 2% skim milk was done for 1 hour.
TOLLIP and actin staining was measured using ECL detection
reagents (Bio-Rad) and imaged with a ChemiDoc Imaging
System (Bio-Rad).

Stimulation of IHMC With TLR Ligands
IHMC monocytes were puriﬁed using CD14+ Microbeads
(Miltenyi) and cultured for 24h in the presence of TLR ligands
(TLR2: 108/ml heat-killed Listeria monocytogenes, TLR3: 10 µg/
ml polyI:C, TLR4: 1 µg/ml E. coli LPS, TLR5: 1 µg/ml B. subtilis
ﬂagellin, TLR8: 5 µg/ml ssRNA40; Invivogen). Supernatants were
collected and measured for the accumulation of 12 different
cytokines and chemokines using Cytometric Bead Arrays
(BD Biosciences).

Data Analysis and Statistics
Statistical analysis was performed with GraphPad Prism 8 and R
V3.5.3. T-sne analysis was performed in FlowJo (parameters: ﬂttsne implementation, max iterations 2000, Theta 0.5, learning
rate 200). The statistical analysis performed for each experiment
is included in the ﬁgure legend. Chemiluminescence was
measured using Image Lab V6.1.0 (Bio-Rad). Outlier analysis
was performed using the Grubb’s method (alpha = 0.05).

Sex Hormone Exposure and TLR
Expression on Monocytes
Total peripheral blood mononuclear cells from 3 healthy
donors were cultured in serum free, phenol red-free RPMI
1640 supplemented with 100 U/ml penicillin, 100 µg/ml
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naturally induced, liver-speciﬁc inﬂammation between men
and women.
We analyzed the kinetics, magnitude, and plasma
immunological proﬁle in 45 chronic hepatitis B (CHB) patients
stopping antiviral therapy (13). The participants in this study
were 43% female (n=19) and 57% male (n=26; Figure 1A).
Patients were stratiﬁed by sex and the median ALT levels were
plotted over a 48w follow-up period. ALT values were
normalized for baseline differences between men and women,
25 U/L for females and 35 U/L for males and displayed as the
upper limit of normal (ULN) (Figure 1B). The peak ALT for
men was signiﬁcantly higher than women (area under the curve
(AUC) ± standard error of the mean; males: 240.6 ± 37.8,
females: 134.7 ± 21.3), indicative of greater liver damage
(Figure 1B). We then calculated the frequency of men or
women who developed a clinical relapse from HBV
reactivation (ALT>1.5xULN and HBV DNA > 2000 IU/ml).

RESULTS
Enhanced Myeloid Inﬂammatory
Responses in Men After HBV Reactivation
To validate clinical observations that males have worsened
disease outcomes in the context of hepatitis, and to identify
inﬂammatory cytokine proﬁles, we chose to investigate
inﬂammatory cytokine production in males and females
following HBV reactivation during nucleoside analogue
cessation. HBV reactivation following nucleoside analogue
cessation induces rapid rebound in HBV replication and
induces liver inﬂammation and damage in a majority of
chronic hepatitis B (CHB) patients (13, 14) However, HBV
exclusively replicates within hepatocytes and naturally derived
virus does not trigger inﬂammatory responses in vivo (15). The
trigger for inﬂammation is currently unknown but HBV
reactivation provides a predictable time frame to compare

A

B

C

D

E

FIGURE 1 | HBV reactivation following treatment cessation induces a myeloid inﬂammatory proﬁle in the plasma of chronic hepatitis B patients. A description of the
cohort has been previously published (13). (A) Distribution of participants sex (n=26 males, 19 female) in the Toronto STOP study. (B) Loess regression curves of
male and female ALT levels as a multiple of upper limit of normal (ALTxULN) during the 48 week follow up to stopping Nuc therapy. (C) Incidence of clinical relapse in
males and females. (D) Proportion of male and female patients who required retreatment after stopping Nuc therapy. (E) Plasma levels of cytokines and chemokines
at 12w and 18w after stopping Nuc therapy relative to baseline values at week 0. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, Mann-Whitney U tests. Figures
depict mean +/- SD.
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compared to the blood (28.69% and 11.23% of HLA-DR+
myeloid cells respectively). CD16+ monocytes made up 1-2%
of HLA-DR+ myeloid cells in both compartments (Figure 2B).
We similarly observed signiﬁcant differences in the frequency of
plasmacytoid DCs between the PBMC and IHMC. The majority
of dendritic cells (DC) in the liver were CD11c myeloid derived
DC. Conventional dendritic cell populations were enriched in
the liver when compared to matched blood (Figure 2B and
Supplementary Table 4). However, CD1a+ DC were extremely
rare within liver perfusions as they have been described as tissue
DCs and, similar to macrophages, likely require tissue digestion
for full mobilization (21). As stated above, we did not ﬁnd
evidence for liver macrophages in the liver perfusion. These
data demonstrate that myeloid frequencies in the liver differ
signiﬁcantly from blood and displayed a composition consistent
with the intrahepatic environment.
We then compared the frequency of myeloid populations
between male and female donors. Sex had no inﬂuence on
myeloid composition (Figure 2C and Supplementary Table
5). Age is associated with inﬂammation (22). Therefore, we
compared myeloid composition by age and, similarly, found
that the intrahepatic myeloid composition did not change with
age (Figure 2D and Supplementary Table 6). Similarly, when
the effect of BMI on myeloid population distribution was
investigated, we did not identify any relationship at healthy,
overweight, and obese BMI with any population (Figure 2E
and Supplementary Table 7). Overall, our data indicated
that biological sex, age, and BMI had a minimal impact on
myeloid composition, suggesting that the functional proﬁle of
myeloid cells may be responsible for the sex-bias in liver
disease progression.

We found that 88% of men experienced clinical relapse, whereas
only 47% of women relapsed (Figure 1C; relative risk of 1.9 (95%
CI 1.23-3.28); p=0.0063). This translated clinically into more
men having to restart antiviral therapy than women (Figure 1D;
relative risk for retreatment for males = 3.65 (95% CI 1.07-13.98),
p=0.047). These clinical data demonstrate that the male liver is
primed for enhanced inﬂammatory responses with a pathological
stimulus during natural infection.
We measured immune markers in the plasma and compared
the change from baseline to immune marker concentrations at
week 12 and 18, which corresponded to the average peak ALT.
We observed a signiﬁcant increase in sCD163, a monocyte/
macrophage activation marker, at week 12 and 18. The
signiﬁcant increase in sCD163 was detectable in both men and
women at week 12 but the magnitude of sCD163 increase was
signiﬁcantly greater in men and persisted until week 18 after
stopping therapy (Figure 1E). Furthermore, we only observed
signiﬁcant increases in IL-6, IL-1a, TNF-a, CXCL-9, CCL4 and
Fas ligand in men after stopping therapy (Figure 1E). CXCL-10
showed signiﬁcant increases in both men and women at week 12
but, again, the magnitude of CXCL-10 was greater in men and
remained signiﬁcantly elevated at 18 weeks post stopping
therapy (Figure 1E). Finally, we found that compared to
females, men produced more sCD163, IL-6, IL-1a, TNF-a,
and CCL4 at week 12. These data show that a liver-speciﬁc
viral infection induces an enhanced myeloid inﬂammatory
signature in men compared to women.

The Intrasinusoidal Myeloid Composition
Does Not Differ by Sex, Age, or BMI
Having veriﬁed the predisposition for men in developing
hepatitis and deﬁning a link to biomarkers of myeloid
activation in active hepatitis in hepatitis B patients, we next
investigated if sex impacts human liver immune composition. To
study the immune composition of the liver, we used portal vein
liver perfusions collected prior to transplant. Liver perfusions
ﬂush non-adherent, intrasinusoidal immune cells from the liver
and have become a recognized source to obtain immune cells
from uninfected liver transplant donors (16–19). We analyzed
the frequency of seven intrasinusoidal and peripheral blood
myeloid populations from liver donors using multiparametric
ﬂow cytometry (Figure 2A). Because neutrophils and other
granulocytes are lost during density centrifugation and do not
survive cryopreservation, these populations have been excluded
from our analysis. In addition, we did not ﬁnd a signiﬁcant
frequency of Kupffer cells in the perfusions using cytospin or
MARCO and TIMD4 staining by ﬂow cytometry (not shown).
Kupffer cells are tightly bound to liver endothelial cells and likely
require tissue digestion for mobilization (20).
The majority of myeloid cells in the intrahepatic
mononuclear cells (IHMC) were classical CD14+ monocytes.
However, classical CD14 monocytes (CD14 MN) were
signiﬁcantly reduced in the IHMC compared to matched
PBMC (67.2 ± 2.6% vs. 86.2 ± 1.9% of HLA-DR+ myeloid cells
respectively). In comparison, the liver contained a signiﬁcantly
higher proportion of CD14+CD16+ intermediate monocytes

Frontiers in Immunology | www.frontiersin.org

TLR-Induced Cytokine Production Is
Increased in Monocytes Isolated From
Male Livers
With no differences in myeloid composition, we tested if the
inﬂammatory potential of intrasinusoidal myeloid cells differed
between males and females, as myeloid cells play key roles in liver
inﬂammation and differentiate into inﬂammatory macrophages
(11, 12). To investigate this, we tested the response of monocytes
to inﬂammatory stimuli. Isolated monocytes were activated with
agonists speciﬁc for TLR2, TLR3, TLR4, TLR5, and TLR8 for
24 h. After stimulation, we measured the production of 12
cytokines and chemokines (IL-1a, IL-1b, IL-6, IL-10, IL-12p70,
CXCL-10, G-CSF, GM-CSF, MCP-1 (CCL2), Mip-1a (CCL3),
Mip-1b (CCL4), and TNF-a). Intrasinusoidal monocytes
robustly produced cytokines and chemokines in response to
stimulation via TLR2, TLR4, TLR5, and TLR8 (Figure 3A).
TLR3 activation was the only condition that induced CXCL-10
production, although overall responses to TLR3 were low in
monocytes (data not shown). We also tested the response of
blood-derived monocytes to TLR agonist stimulation (Figure 3B).
We observed signiﬁcant differences in cytokine/chemokine
production between male and female liver monocytes after
stimulation of TLR2, TLR4, TLR5, and TLR8. The immune
markers showing the most signiﬁcant differences were IL-6 and
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B

A
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D

E

FIGURE 2 | Intrahepatic mononuclear cells from liver perfusions display a proﬁle of organ-speciﬁc immune cells. (A) Flow cytometry panel to measure the frequency
of IHMC and matched PBMC myeloid frequencies. (B) Summarized myeloid cell frequencies between blood and liver (blood n=27, liver n = 30). Data on frequency
displayed as percent of HLA-DR+ cells. Percent of total HLA-DR+ cells for each myeloid population based on (C) Sex (n=18 males, 12 females), (D) Age (<30, n= 8;
30-60, n=15; >60, n=7), or (E) BMI (18.5-24.9 n=13; 25-29.9 n=8; >30 n=9). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, Statistical analyses: Mann-Whitney U
tests and Kruskal-Wallis tests followed by Dunn’s multiple comparisons test when comparing cell frequencies by sex and across age groups.

time of organ transplant (Supplementary Figure 2). The most
signiﬁcant differences in cytokine/chemokine production were
consistently observed after stimulation of TLR8, followed by
TLR5, TLR2, and TLR4.
To determine if this differential response between male and
female monocytes was restricted to the liver, we isolated
monocytes from the peripheral blood of men and women and
compared cytokine and chemokine production. In contrast to
the intrasinusoidal data, signiﬁcant difference between blood
monocytes from men and women were much more restricted,

IL-1a and the chemokines CCL3, CCL4, and CCL2 (Figure 3A).
TNF-a, IL-10, IL-1b, and G-CSF also showed signiﬁcant
differences between men and women with select TLR
stimulation (Supplementary Figure 1). CXCL-10, GM-CSF,
and IL-12p70 did not show signiﬁcant differences between
men and women (Supplementary Figure 1). We did not ﬁnd
a signiﬁcant correlation between spontaneous cytokine
production and alanine aminotransferase (ALT) levels, the
clinical marker of liver damage, conﬁrming the differences
between men and women were not due to liver damage at the
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A

B

FIGURE 3 | Sex-based differences in cytokine and chemokine production by monocytes following in vitro TLR stimulation of enriched CD14+ monocytes after 24
hours. Cytokine/chemokine production by (A) Liver and (B) peripheral blood isolated CD14+ monocytes after stimulation with TLR agonists. (IHMC males, n=18;
females=14; PBMC: males, n=18; females, n=19; For CCL4 PBMC males, N=5; females=4) *p < 0.05, **p < 0.01, ***p < 0.001, Mann-Whitney U tests. Figures
depict mean +/- SD.

No Phenotypic Difference in
Intrasinusoidal Monocytes Between
Men and Women

with only IL-1a and CCL3 showing signiﬁcant difference after
TLR4 stimulation, and CCL2 after TLR2 and TLR8 stimulation
(Figure 3B). All other responses did not show a signiﬁcant
difference between men and women in blood monocytes
(Figure 3B and Supplementary Figure 1). These data show
that, while statistically signiﬁcant functional differences are
detectable in the blood, functional differences between male
and female monocytes are magniﬁed in the liver and male liver
monocytes respond to inﬂammatory stimuli with enhanced
cytokine and chemokine production.

Frontiers in Immunology | www.frontiersin.org

With no difference observed in monocyte frequency, but a
signiﬁcant difference in function, we sought to determine if the
liver environment altered monocyte phenotype between men
and women, potentially enhancing their response to activating
signals. Therefore, we performed deeper phenotypic analysis on
monocytes, measuring the expression of scavenger receptors
(CD68, CD163), complement receptors (CD35, CD88), Fc
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testosterone had no impact on the frequency, or staining
intensity, of IL-6 or CCL4 in CD14+ MN compared to
untreated cells (Figure 5A). We then investigated whether
TLR5 or TLR8 expression differed, at both the mRNA or
protein level. We found no difference between male and
female liver monocytes in terms of TLR5 and TLR8 mRNA
expression, the percent of liver monocytes expressing the TLRs
or the level of TLR expression based on mean ﬂuorescence
intensity (Figure 5B). Therefore, neither sex hormone
exposure nor TLR expression could explain differences in
cytokine/chemokine production between male and female
liver monocytes.
Because we observed reduced cytokine and chemokine
production in ex vivo stimulated monocytes from female livers,
we chose to investigate negative regulators of TLR signaling.
Speciﬁcally, we investigated the expression of both IRAK-M and
TOLLIP. The expression of IRAK-M did not differ by sex.
However, we observed that female liver monocytes expressed
more TOLLIP when compared to male liver monocytes. When
we investigated the expression of TOLLIP in blood monocytes,

receptors (CD16, CD32, CD64) and integrins (CD11c, CD11b)
on CD14+ MN and CD14/CD16+ MN (Figure 4A). We did not
observe any signiﬁcant phenotypic differences between
monocytes from male and female livers (Figure 4B). This data
indicates that neither the composition nor phenotype of
monocytes differs signiﬁcantly by sex.

Regulation of TLR-Induced
Cytokine Production
With no difference in frequency or phenotype of male liver
monocytes to explain heightened inﬂammatory responses, we
next investigated whether sex hormones, genetic expression, or
the TLR signaling cascade showed differences between men and
women. We focused our mechanistic analysis on TLR8 and
TLR5 as these TLRs displayed the most signiﬁcant functional
differences between men and women. In addition, TLR8 is
located on the X chromosome while TLR5 is not, allowing us
to compare whether genetic expression plays a role. We ﬁrst
tested the effect of sex hormone exposure on TLR8-induced IL-6
and CCL4 production. Pre-incubation with either estrogen or

A

B

FIGURE 4 | No differences in monocyte phenotype based on sex. (A) Surface phenotype of liver CD14+ and CD14+CD16+ monocytes. T-SNE dimensionality
reduction was performed on monocytes concatenated from all liver samples (5000 cells per sample). (B) Expression of surface markers in monocyte subsets by sex
n=18 males, 12 females. Figures depict mean +/- SD.
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A

B

C
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D
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G

FIGURE 5 | Investigation of TLR expression and signaling. (A) Total HD PBMCs from exposed to estrogen or testosterone for 18 hours were stimulated with TLR8
agonists in the presence of Brefeldin A and IL-6 and CCL-4 production in CD14+ MN were measured by ﬂow cytometry. Data displayed as percent of monocyte
positive for each cytokine(top) or MFI (bottom) n=3 PBMC donors. (B) TLR expression in male and female liver monocytes. mRNA measured by qPCR (left) and
protein expression measured by ﬂow cytometry (right) n=5 males, 5 females. (C) Analysis of negative regulators of TLR signaling. TOLLIP expression was measured
in both the liver (left) and blood (right). PBMC n=5 male, 5 female; IHMC n=3 male, 3 female. (D) Representation of TOLLIP’s intersection of the TLR signaling
cascade to demonstrate the potential to inﬂuence all TLRs. (E) Example western blot of TOLLIP protein (top) and Actin (bottom) in puriﬁed CD14+ monocytes. (F)
TOLLIP isoform expression in blood monocytes does not show a signiﬁcant relationship between sex and the expression of TOLLIP. (G) TOLLIP isoform 2
expression is elevated in female liver monocytes. Densitometry data was subject to outlier analysis with Grubb’s method. PBMC n=5 male, 5 female; IHMC n=4
males, 8 female, *p<0.05, **p<0.01, ns, non-signiﬁcant, Mann-Whitney U tests. Figures depict mean +/- SD.

we did not ﬁnd that sex inﬂuenced TOLLIP expression
(Figure 5C). We also investigated expression of key molecules
in the TLR signaling cascade and terminal transcription factors
for TLRs signaling, including MyD88, IRAK-4, IRAK-1, TRAF6, RelA (NF-ĸB), and IRF-7 (Supplementary Figures 3A, B), but
found no statistically signiﬁcant differences between male and
female liver monocytes. These data suggest liver-restricted
regulation of TOLLIP, with increased expression of the
negative regulator of TLR signaling in female liver monocytes.
TOLLIP regulates IRAK phosphorylation and is known to
suppress TLR-mediated inﬂammatory cytokine production in
human monocytes [Figure 5D (23)]. To determine if differences
in mRNA expression translated to differences in TOLLIP protein

Frontiers in Immunology | www.frontiersin.org

expression, we used Western blot to conﬁrm TOLLIP protein
expression in liver monocytes from donors who underwent
living donor liver transplants. Western blot data identiﬁed two
known isoforms (isoform 1 and isoform 2; 30.2 and 24.6 kDa,
respectively) of TOLLIP protein in both male and female
monocytes (Figure 5E and Supplementary Figures 4A, B).
Comparison of the expression of TOLLIP isoform 1 and 2 in
monocytes from 10 PBMC donors revealed no statistically
signiﬁcant difference in expression between males and females
(Figure 5F). Quantiﬁcation of TOLLIP expression in liver
monocytes revealed that while TOLLIP isoform 1 expression
was similar between males and females, we found that the
expression of TOLLIP isoform 2 was statistically signiﬁcantly
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elevated in female liver monocytes (Figure 5G). These data
suggest that the MyD88 signaling cascade may be differentially
regulated between the blood and liver and between men and
women within the liver.

majority of patients stopping antiviral therapy (38, 39).
Therefore, we believe the immune proﬁle we detected in the
CHB patient cohort is derived from the liver and is indicative of
monocyte activation. While we were unable to investigate the
relationship between different myeloid populations in the blood
and liver in this study cohort, it has been reported that HBV
DNA and HBV antigens do not inﬂuence the distribution of
myeloid population in blood (40, 41). However, investigating
dynamic changes in these immune populations during active
hepatitis may be key to understanding population and phenotype
kinetics in in vivo inﬂammation.
Identiﬁcation of speciﬁc mechanisms regulating sex-biased
immune responses have been challenging due to the broad effects
of genetics, environment and hormones (42). Sex hormone
concentrations ﬂuctuate and regulate the promoters of multiple
immune-related genes. The X chromosome harbors numerous
immune genes, including TLR7 and TLR8, and microRNAs with
reported effects on immune function (43). We focused our
mechanistic studies on TLR8 and TLR5, which allowed us to
compare hormone and X chromosome dependent effects on
protein expression. Our observation, that cytokine and
chemokine production were similar in peripheral blood
monocytes between men and women argues against direct
regulation by sex hormones, as these hormones are systemic.
Our in vitro mechanistic data involving sex-hormone exposure
supported this conclusion, which was also found in the HFGP
cohort (29). Similarly, our data did not show differences in
mRNA or protein expression between TLR5 and TLR8,
arguing against increased expression from the X chromosome.
Finding a signiﬁcant difference in cytokine production after
stimulation with all TLR agonists suggested a common
mechanism in the signaling cascade. This would be similar to
the regulation of IFN-a production after TLR7 stimulation in
female plasmacytoid DC, where the terminal transcription factor,
IRF-5 was increased (44). Our interrogation of the signaling
cascade determined that the negative regulator of TLR signaling,
TOLLIP, was expressed at higher levels in female liver monocytes
compared to male monocytes, with no difference in the blood,
suggesting liver-speciﬁc regulation of the TOLLIP promoter.
TOLLIP interacts with the IRAK complex to reduce
downstream phosphorylation events, reducing cytokine
production in human monocytes (23, 45, 46). Recent studies
have demonstrated that transduction of primary human
monocytes with short hairpin RNA to knockdown TOLLIP
enhanced cytokine production following TLR stimulation (23).
Similarly, overexpression of TOLLIP in murine monocytes could
dramatically suppress TLR signaling through NF-ĸB dependent
pathways (47). Our Western blot data conﬁrmed TOLLIP
protein expression in both blood and liver monocytes from
men and women. With our limited sample size for protein
analysis, we observed a statistically signiﬁcant increase in
TOLLIP isoform 2 in female liver monocytes. The intersection
of TOLLIP with the TLR signaling cascade is consistent with our
functional data demonstrating that TLR2, -5, and -8, which
signal through MyD88-IRAK, showed the most signiﬁcant
differences. This data is also consistent with the key role of

DISCUSSION
It is generally accepted that females display stronger cell
mediated immune responses than males. Females have
increased CD4 T cells (24), show stronger responses to
vaccination (25–27) and have higher incidence of autoimmune
disorders mediated by cells of the adaptive immune system (28).
However, the inﬂammatory potential of innate immunity
between men and women is less clearly deﬁned and may be
restricted to speciﬁc cell types or speciﬁc receptors. An extensive
study performed by Human Functional Genomics Project
(HGFP) found that monocyte-derived cytokines were higher in
men vs. women (29). This study stimulated whole blood and
PBMC from 500 healthy volunteers and found higher IL-6, IL-1b
and TNF-a in males. The study was of low resolution in
identifying relevant cell populations as they used whole blood
and PBMC, instead of puriﬁed monocytes. Further, this study
required a large patient cohort to demonstrate differences but are
consistent with our data on puriﬁed monocytes. Similarly, a
recent study also supported the observation of enhanced
inﬂammatory potential of peripheral blood male monocytes,
but analysis was focused on TNF-a, CXCL1, and CCL2 (30).
Our data indicates that differences in cytokine production
between male and female monocytes was magniﬁed in the
liver, suggesting regulation, at least in part, by a tissuespeciﬁc effect.
We ﬁrst validated the clinical observations that men have
worsened outcomes in hepatitis through a clinical cohort of
patients with chronic HBV infection going through treatment
withdrawal. We found that sCD163 was the most statistically
signiﬁcantly elevated marker in patients with HBV reactivation.
Importantly, CD163 is expressed on monocytes and
macrophages and is shed from their surface upon TLR
activation (31, 32). Further, previous work has correlated
sCD163 with HBV-related liver inﬂammation (33, 34). The
increased inﬂammatory proﬁle in male patient plasma was
consistent with subsequent TLR activation on monocytes and
macrophages. The myeloid cytokine/chemokine proﬁle we
observed in CHB patients matched closely with our ex vivo
liver monocyte data, with higher IL-6, IL-1a, CCL-4, and TNF-a
observed in male donors. Plus, additional chemokines, CXCL-9
and CXCL-10, were higher in men and have been associated with
liver inﬂammation (35, 36). It is possible that the inﬂammatory
cytokine proﬁle we observed in CHB patients was not produced
by liver-resident monocytes/macrophages, but this scenario is
unlikely. HBV virions and antigens constantly circulate through
the peripheral blood at high levels for the lifetime of the patients
and do not engage innate inﬂammatory mechanisms (15, 37). In
contrast, HBV reactivation triggers a poorly understood liverspeciﬁc danger signal, which induces liver inﬂammation in a
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MyD88-dependent IL-6 production in the development of liver
cancer in male mice (48). In contrast, TLR4 signaling can bypass
MyD88-IRAK through the TRIF pathway and showed the fewest
signiﬁcant differences between male and female liver monocytes.
Identiﬁcation of key factors that can dampen inﬂammatory
cytokine production in the human liver may yield targets to
treat, and slow the progression of, multiple types of
inﬂammatory liver disease.
We recognize there are caveats to our uninfected liver
analysis. Liver perfusion samples are collected from deceased
donors. All the livers used in our analysis were used for
transplantation, verifying the quality of the organs. The cause
of death or age at death could skew results. However, cause of
death was distributed among all categories for both men and
women. Age at death was not signiﬁcantly different and ex vivo
cytokine production did not correlate with the donor’s APRI
score (not shown) or ALT levels. Therefore, we are conﬁdent the
differences we observed are physiologically accurate and not a
consequence of the liver donors. Additionally, the cells available
for analysis from the perfusion samples are those that can be
ﬂushed from the sinusoid upon portal vein perfusion. These were
highly representative of liver derived cells but also do not capture
tightly bound macrophages or parenchymal cells. Until the data
are obtained, whether macrophages or parenchymal cells
respond with heightened inﬂammatory potential remains an
open question.
Our study characterizes the human liver, between sexes, in the
absence of underlying liver disease. This data is vitally important
to understanding the mechanisms driving liver inﬂammation
that put hundreds of millions of individuals at risk of developing
cirrhosis and liver cancer. We believe the sex-bias inﬂammatory
potential is a general phenomenon of the intrasinusoidal
environment. Elucidating liver-speciﬁc regulation of cytokine
production between men and women, will further improve
efforts to manage the pathogenesis of liver disease.
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